Insights into ASX Stocks

Nyrada (ASX: NYR) $14M Capital Raise: Fueling the Path to Global Pharma Partnerships

Sep 22, 2026

Proactive Equities Team

As Nyrada (ASX: NYR) raises $14 million to advance Xolatryp through Phase IIa trials, the funding extends its development runway and could accelerate clinical milestones, potentially positioning the company for future partnerships with global pharmaceutical companies.

Kaoko Metals (ASX: KAO): Ramps Up Namibia Copper Hunt with Second Drill Rig

Sep 22, 2026

Proactive Equities Team

Kaoko Metals has mobilised a second drill rig at its Chalkos Copper-Silver Project in Namibia, testing Donkey Hill and Otniel simultaneously as it accelerates exploration following a recent $23m capital raise.

Macroeconomic Report for the Week Ending 20 September 2026 – Australian Market Outlook

Sep 22, 2026

Proactive Equities Team

Global markets were volatile as higher US rates and Saudi pipeline disruption lifted oil costs, strengthened the dollar and pressured risk assets. Australia faces slowing growth, persistent inflation and a cautious ASX, with healthcare resilient while materials, technology and real estate weakened.

4DMedical (ASX: 4DX): Pricing the Future of Lung Imaging

Sep 21, 2026

Proactive Equities Team

4DMedical is scaling its lung-imaging software portfolio, led by CT:VQ, across hospitals and imaging networks. FY26 scan volumes rose 77% to 344,075, while cash reached A$278m; however, the company remains loss-making as it pursues commercial adoption and revenue growth.

AdAlta (ASX: 1AD) $120M Deal: Proof of Platform, Not Profit

Sep 21, 2026

Proactive Equities Team

While AdAlta (ASX: 1AD) is not the recipient of the $120 million deal, this agreement could do wonders for its IRO technology platform by validating it and making future product development through the platform easier and faster.

Mount Ridley Mines (ASX: MRD): Selectro Process Impresses as Shares Approach Resistance

Sep 21, 2026

Proactive Equities Team

Mount Ridley Mines (ASX: MRD) achieved a 91.8% scandium recovery breakthrough with its Selectro™ process, using half the reagent dose, at its largest scandium resource. Shares trade in an uptrend, though technicals suggest limited room for an entry at current levels.

1...25 26 27...81

Page 26 of 81

1...25 26 27...81

Page 26 of 81